LIMK1 and breast carcinoma: For example, Bagheri-Yarmand et al. proposed that LIMK1 increases tumor metastasis of human breast cancer cells through stimulation of urokinase-type plasminogen activator system and degradation of the extracellular matrix by the serine protease urokinase type plasminogen activator [168].